CLOs on the Move

Assembly Biosciences

www.assemblybio.com

 
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.assemblybio.com
  • 331 Oyster Point Boulevard 4th Floor
    South San Francisco, CA USA 94080
  • Phone: 833.509.4583

Executives

Name Title Contact Details
Jason Okazaki
Chief Legal and Business Officer Profile

Similar Companies

Western Missouri Medical Center

Western Missouri Medical Center (WMMC) is a fully-accredited acute care facility located in Warrensburg, Missouri. A not-for-profit county Medical Center, WMMC offers comprehensive health care services to residents of Johnson County and west central Missouri. Through collaborating with our medical staff and integrating advanced technology, WMMC continues to grow as a progressive Medical Center that will continue to meet the evolving needs of the greater community.

Ampio Pharmaceuticals

Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates.  These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending.  Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™.  The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.  Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema.  Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.

Ambulatory Anethesia Associates Of Montgomery Pc

Ambulatory Anethesia Associates Of Montgomery Pc is a Montgomery, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kaiser Permanente

Kaiser Permanente is an American integrated managed care consortium, based in Oakland, California, United States, founded in 1945 by industrialist Henry J.

Stelkast

Stelkast is a Canonsburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.